Short-term Effects Kinesiotaping (KT) on Balance and Gait in Parkinson's Disease (DP)

Parkinson Disease Clinical Trial

— KT-DP  

Official title:

Short-term Effects Kinesiotaping (KT) on Balance and Gait in Parkinson's Disease (DP)

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04326647
• Other study ID #: jma002
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 1, 2020
• Est. completion date: August 1, 2020

Study information

• Verified date: March 2020
• Source: University of Castilla-La Mancha
• Contact: Javier Merino Andrés, MsC
• Phone: 925268800
• Email: Javier.Merino[@]uclm.es
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To analyze the short-term effect of kinesiotaping in balance and gait on Parkinson's disease

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 10
• Est. completion date: August 1, 2020
• Est. primary completion date: August 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Diagnosis of stage III PD, according to the Hoehn and Yahr scale.

• Subjects who are in the age range of 50 to 80 years.

• Acceptance of informed consent.

• Not present a musculoskeletal disorder or other neurological disease that interferes with balance and / or walking.

• Not having a diagnosed vestibular disorder.

Exclusion Criteria:

• Diagnosis of parkinsonism o Parkison-Like.

• Taking medications that may interfere with the different variables evaluated.

• Allergy to any component of the bandage.

• Being a pacemaker.

Related Conditions & MeSH terms

• Kinesiotaping
• Parkinson Disease

Intervention

Other:
• Kinesiotaping
We used kinesiotaping in gastrocnemius and lumbar back
• Exercise
Exercises about balance and gait

Locations

Country	Name	City	State
Spain	Javier Merino Andrés	Toledo

Sponsors (1)

Lead Sponsor	Collaborator
University of Castilla-La Mancha

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Berg Test - T0	Berg Test pre-intervention	up to week
Primary	Berg Test - T1	Berg Test post-intervention two days	up to week
Primary	Berg Test - T2	Berg Test post-intervention seven days	up to week
Primary	Tinetti Gait Test - T0	Tinetti Gait Test pre-intervention	up to week
Primary	Tinetti Gait Test - T1	Tinetti Gait Test post-intervention two days	up to week
Primary	Tinetti Gait Test - T2	Tinetti Gait Test post-intervention seven days	up to week
Primary	Up & Go Test - T0	Up & Go Test pre-intervention	up to week
Primary	Up & Go Test - T1	Up & Go Test post-intervention two days	up to week
Primary	Up & Go Test - T2	Up & Go Test post-intervention seven days	up to week
Primary	Parkinson's Disease Questionnaire - T0	Parkinson's Disease Questionnaire pre-intervention	up to month
Primary	Parkinson's Disease Questionnaire - T1	Parkinson's Disease Questionnaire post-intervention	up to month
Primary	surface electromyography -T0	surface electromyography pre-intervention	up to week
Primary	surface electromyography -T1	surface electromyography post-intervention two days	up to week
Primary	surface electromyography -T2	surface electromyography post-intervention seven days	up to week